文献速递慢性静脉疾病

腹股沟再手术治疗复发性大隐静脉瓣膜功能不全的长期疗效

Long-term efficacy of inguinal reoperation for recurrent saphenofemoral incompetence.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2025-11-12

本研究回顾性纳入2015–2016年接受腹股沟再手术的84例患者(94条腿),并进行前瞻性随访,中位随访6.6年。结果显示再手术长期疗效良好:仅5.3%的腿在腹股沟区检出 duplex 超声 reflux,临床复发率为2.1%,疾病严重程度低且患者满意度高。作者认为,在采取特定技术策略预防新生血管形成的前提下,开放再手术仍是治疗腹股沟复发的合适选择。

要点

  • 腹股沟再手术中位随访6.6年,仅5.3%的腿在腹股沟区检出 duplex 超声 reflux。
  • 临床复发率低(2.1%),疾病严重程度评分低,94.1%患者愿意再次接受该手术。
  • 开放再手术在预防新生血管形成的前提下长期疗效可能优于微创方法,需对比研究验证。

核心结论

  • 腹股沟再手术在采取特定技术策略预防新生血管形成时非常有效。
  • 长期疗效可能优于微创方法,但需开展对比研究。
  • 在对比研究结果出来前,开放再手术仍应视为腹股沟复发的合适治疗选择。

研究设计与样本

  • 回顾性识别2015–2016年接受腹股沟再手术的患者,并进行前瞻性随访检查。
  • 共纳入84例患者(94条治疗腿),中位随访6.6年。
  • 手术在全麻加肿胀局麻下作为住院治疗进行,包括SFJ flush religation、残端缝合、游离内皮烧灼和新生血管去除。

主要发现

  • 94条腿中5条(5.3%)在腹股沟区检出 duplex 超声 reflux,仅1条腿(1.1%)显示2级新生血管(血管直径≥4 mm)。
  • 根据REVAS分类,94条腿中2条(2.1%)出现源自腹股沟区的临床复发。
  • 随访时疾病严重程度低:平均rVCSS(0–30)为1.8 ± 1.8,平均HHVSS(0–33)为3.9 ± 3.4。
  • 根据CEAP分类,55%的治疗腿疾病分期显著改善(P < .001)。
  • 94.1%的患者表示如果医学建议会再次接受腹股沟再手术。

临床怎么用

  • 对于腹股沟复发性大隐静脉瓣膜功能不全,开放再手术仍可作为治疗选项。
  • 再手术中应实施flush religation、残端缝合、内皮烧灼和新生血管去除等技术策略以预防新生血管形成。
  • 术后长期随访可采用 duplex 超声、REVAS分类、rVCSS、HHVSS和CIVIQ等标准化工具评估疗效。

局限性

  • 本研究为回顾性识别患者后前瞻性随访,非随机对照设计。
  • 样本量有限(84例患者,94条腿),可能影响结果的普遍性。
  • 缺乏与微创方法的直接对比数据,需进一步比较研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Recurrence originating from the saphenofemoral junction (SFJ) after an open surgical approach to or endovenous ablation of the great saphenous vein frequently occurs. The optimal treatment for a saphenofemoral recurrence remains a subject of debate. Currently, open redo surgery is becoming less common. This study analyzes the long-term effectiveness of saphenofemoral redo surgery following the principles of a modern surgical approach. METHODS: Patients who underwent saphenofemoral reoperation in 2015 and 2016 were identified retrospectively and invited to participate in a prospective follow-up examination. Redo surgery was performed under general and additional tumescent local anesthesia as inpatient treatment and included flush religation of the SFJ , stump suture, cauterization of the free endothelium, and removal of neovascularization. The following objectives were analyzed: Duplex ultrasound-detectable recurrent reflux at the SFJ, clinical recurrence according to Recurrent Varices After Surgery classification, disease severity and quality of life using standardized protocols (Revised Venous Clinical Severity Score, Homburg Varicose Vein Severity Score, Chronic Venous Insufficiency Questionnaire), and patient-reported satisfaction. RESULTS: A total of 84 patients (94 treated legs) were included with a median follow-up of 6.6 years. Five of the 94 legs (5.3%) had a duplex-detected reflux in the groin, with only 1 leg (1.1%) showing grade 2 neovascularization (vessel diameter of ≥4 mm). According to Recurrent Varices After Surgery classification, 2 of the 94 legs (2.1%) revealed clinical recurrence arising from the inguinal region. Disease severity at follow-up was low with a mean Revised Venous Clinical Severity Score(0-30) of 1.8 ± 1.8 and a mean Homburg Varicose Vein Severity Score (0-33) of 3.9 ± 3.4. According to the Clinical, Etiological, Anatomical and Pathological classification, the stage of disease improved significantly (P < .001) in 55% of the treated legs. The procedure was well-accepted by patients: 94.1% indicated they would undergo saphenofemoral reoperation again if medically advised. CONCLUSIONS: This study demonstrates that saphenofemoral redo surgery is very effective when certain technical strategies are implemented to prevent neovascularization. Long-term treatment results may be superior to minimally invasive procedures, indicating the need for comparative studies. Until such studies are available, open redo surgery should continue to be considered as an appropriate treatment option for saphenofemoral recurrence.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Doncheva EV, Gerontopoulou SA, Altindas-Jürgensen C, et al. Long-term efficacy of inguinal reoperation for recurrent saphenofemoral incompetence. J Vasc Surg Venous Lymphat Disord. 2025. PMID: 41238060. doi:10.1016/j.jvsv.2025.102353

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。